ELVN-002 in Solid Tumors with a HER2 Genetic Alteration

HER2 amplified or HER2 positive solid tumor Phase 1a Dose Escalation Combination with T-DXd: HER2 mutant Non-small Cell Lung Cancer Phase 1a Dose Escalation Combination with T-DM1: HER2 positive Metastatic Breast Cancer Phase 1b Monotherapy Dose Expansion: HER2 mutant Non-small Cell Lung Cancer, Phase 1a Monotherapy Dose Escalation and Exploration: HER2 mutant

No related papers found yet.

None listed

France, Italy, Spain